Stocks

Ginkgo Bioworks Holdings DNA

Health care sectorNYSE

What to see in Ginkgo Bioworks Holdings now

Who bought more than 5%?7.7%

BlackRock holds 7.7% · +1.2pp on the report before

Filed 07/30
Is Wall Street adding or cutting?+8

183 13F filers hold it · +8 against the quarter before · shares held +11.9%

Holdings of 06/30
Is stock about to come to market?$51.4K

$51.4K of planned sales filed in 30 days · under 0.1% of the units outstanding

Filed 09/17

Company

Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Boston, Massachusetts
Fiscal year end
12/31
Next earnings
11/04, estimated
  • $51.4K of planned sales filed in 30 days · under 0.1% of the units outstandingFiled 09/17

Insider trades

Trade type
Steven P. CoenSee remarks
Open-market sale05/2205/26307 sh$8.33$2,557.31−0.6%
Steven P. CoenSee remarks
Open-market sale04/1704/20324 sh$7.95$2,575.8−0.6%
Steven P. CoenSee remarks
Open-market sale04/1304/1433,171 sh$6.41$212,626.11−40.0%
Open-market sale04/1004/13124,727 sh$6.43$801,994.61−22.2%
Open-market sale04/1004/13124,727 sh$6.43$801,994.61−22.2%
All insider trades in Ginkgo Bioworks Holdings

Planned sales

Ginkgo Bioworks HoldingsDNA10b5-1 plan
2,200 sh$16,03809/17Filed 09/17
Ginkgo Bioworks HoldingsDNA
5,000 sh$35,405.9909/15Filed 09/15
Ginkgo Bioworks HoldingsDNA
330 sh$2,302.4708/24Filed 08/24
Ginkgo Bioworks HoldingsDNA10b5-1 plan
2,200 sh$14,65208/17Filed 08/17
Ginkgo Bioworks HoldingsDNA
752 sh$5,943.2807/17Filed 07/17
Ginkgo Bioworks HoldingsDNA10b5-1 plan
2,200 sh$17,73206/10Filed 06/10
Ginkgo Bioworks HoldingsDNA
307 sh$2,558.6305/22Filed 05/22
Ginkgo Bioworks HoldingsDNA10b5-1 plan
2,200 sh$18,21605/13Filed 05/13
Ginkgo Bioworks HoldingsDNA
324 sh$2,576.3604/17Filed 04/17
Ginkgo Bioworks HoldingsDNA10b5-1 plan
2,200 sh$17,11604/15Filed 04/15
All planned sales of Ginkgo Bioworks Holdings

26-week trading